Essential Partners »

Genes shares owned by Essential Partners

Quarter-by-quarter ownership of Genes (GCO) shares owned by Essential Partners from 13F filings

Historical chart of Essential Partners investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by Essential Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by Essential Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.1k 71 28.99
2025-12-31 $124 5 24.80
2025-09-30 $290 10 29.00
2025-06-30 $59 3 19.67

More positions owned by Essential Partners

Sprott Gold Convert to Physical Cef (PHYS)
Comfort Sys Usa Stock (FIX)
Nvidia Corporation Stock (NVDA)
Schwab Fundamental Int'l Broad Etf (FNDF)
iShares S&P 500 Etf (IVV)
Schwab Fundamental U.S. Broad Etf (FNDB)
Vanguard Short-Term USTS Etf (VGSH)
General Mtrs Stock (GM)
Ge Aerospace Stock (GE)
Merck & Co Stock (MRK)
Technipfmc Stock (FTI)
Ge Vernova Stock (GEV)
Teradyne Stock (TER)
Incyte Corp Stock (INCY)
Pnc Finl Svcs Group Stock (PNC)

View all positions for Essential Partners

Top funds holding Genes

Pzena Investment Management
BlackRock
Vanguard Group
Dimensional Fund Advisors
Vanguard Capital Management
Acadian Asset Management
Fund 1 Investments
Charles Schwab Investment Management
Citadel Advisors
Healthcare Of Ontario Pension Plan Trust Fund
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Kingdon Capital Management
Geode Capital Management
State Street Corporation

View all funds holding Genes